[Molecular principles of alternative treatment approaches for hormone-refractory prostate cancer]

Area of Science:

• Oncology
• Nutritional Science
• Molecular Biology

Context:

• Prostate cancer incidence varies geographically, with higher rates in Western countries compared to Asian societies.
• The lack of curative treatments for hormone-refractory prostate cancer necessitates the exploration of novel therapeutic strategies.
• Dietary factors, particularly phytoestrogens found in soy, are hypothesized to contribute to prostate cancer prevention.

Purpose:

• To investigate the potential of phytoestrogens and histone deacetylase inhibitors as therapeutic agents for prostate cancer.
• To explore the mechanisms by which these agents may reduce tumor invasiveness and improve survival strategies.
• To analyze the impact of these compounds on gene expression related to androgen receptor and IGF receptor signaling.

Summary:

• Phytoestrogens and histone deacetylase inhibitors share the ability to modulate aberrant androgen receptor and IGF receptor signaling.
• These agents can potentially diminish tumor invasiveness and acquired survival mechanisms.
• Reduced tumor cell proliferation and prostate-specific antigen (PSA) secretion are observed, alongside altered gene expression patterns.

Impact:

• Findings suggest novel therapeutic avenues for hormone-refractory prostate cancer, leveraging nutritional compounds and epigenetic modifiers.
• RNA interference studies provide functional insights into the gene expression events underlying the beneficial effects of these compounds.
• This research contributes to understanding the molecular basis of prostate cancer prevention and treatment through dietary and pharmacological interventions.